You are here

Right or Left? In Colorectal Cancer, Side Matters

Eric Van Cutsem, MD, PhD, Co-Chairman of the 2017 ESMO World Congress on Gastrointestinal Cancer, explains why side matters in colorectal cancer. Left-sided tumors have different and often better outcomes, responding better to some therapies than their right-side counterparts. However, research is zeroing in on treatments to fight right-side tumors more effectively.

2017 ESMO World Congress on Gastrointestinal Cancer

More Headlines

New, One-Time Corticosteroid for Post-Surgical Ocular Pain Approved
Resorbable Dextenza is the First Intracanalicular Insert for Drug Delivery
Lemtrada Can Cause Serious, But Rare, Risk of Stroke and Tears in Artery Lining
Patients with MS Suffered Stroke, Blood Vessel Tearing in Head and Neck After Receiving Drug
FDA Approves Truxima for Non-Hodgkin’s Lymphoma
First Biosimilar For Adults With CD20-Positive, B-Cell Non-Hodgkin’s Lymphoma
Symptoms of Differentiation Syndrome Going Unrecognized with Idhifa
Life-Threatening Side Effect of Drug for Acute Myeloid Leukemia
Firdapse Approved for Treatment of Lambert-Eaton Myasthenic Syndrome
First Drug for Rare Autoimmune Disorder That Affects Nerve, Muscles Connection
Xospata Approved for Acute Myeloid Leukemia With FLT3 Mutation
Hope For Patients With Highly Aggressive Form of AML
FDA Approves Vitrakvi for TRK Fusion Cancers
Oncology Therapy for Adult and Pediatric Tumors With a Neurotrophic Receptor Tyrosine Kinase (NTRK) Gene Fusion
New Treatment for Acute Myeloid Leukemia
First Hedgehog Pathway Inhibitor Approved for AML in Adults Aged 75 and Older
RP-L102 Offers Hope for Children With Fanconi Anemia
Gene Therapy Granted Regenerative Medicine, Fast Track Designations